These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9773782

  • 1. Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis.
    Noguchi K, Yoshikawa N, Ito-Kariya S, Inoue Y, Hayashi Y, Ito H, Nakamura H, Iijima K.
    J Am Soc Nephrol; 1998 Oct; 9(10):1815-25. PubMed ID: 9773782
    [Abstract] [Full Text] [Related]

  • 2. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor.
    Iijima K, Yoshikawa N, Connolly DT, Nakamura H.
    Kidney Int; 1993 Nov; 44(5):959-66. PubMed ID: 8264155
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells.
    Pupilli C, Lasagni L, Romagnani P, Bellini F, Mannelli M, Misciglia N, Mavilia C, Vellei U, Villari D, Serio M.
    J Am Soc Nephrol; 1999 Feb; 10(2):245-55. PubMed ID: 10215323
    [Abstract] [Full Text] [Related]

  • 4. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
    Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ.
    Am J Pathol; 1995 Dec; 147(6):1715-27. PubMed ID: 7495296
    [Abstract] [Full Text] [Related]

  • 5. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.
    Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF.
    J Am Soc Nephrol; 1996 May; 7(5):661-6. PubMed ID: 8738799
    [Abstract] [Full Text] [Related]

  • 6. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
    Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes J, Isner JM.
    Am J Pathol; 1997 May; 150(5):1673-85. PubMed ID: 9137092
    [Abstract] [Full Text] [Related]

  • 9. Involvement of IL-6 in mesangial proliferative glomerulonephritis.
    Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y.
    J Immunol; 1989 Dec 15; 143(12):3949-55. PubMed ID: 2592764
    [Abstract] [Full Text] [Related]

  • 10. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
    Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF.
    Cancer; 1996 Aug 01; 78(3):454-60. PubMed ID: 8697391
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF.
    Cancer Res; 1993 Oct 01; 53(19):4727-35. PubMed ID: 8402650
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin.
    Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP.
    J Invest Dermatol; 1997 Mar 01; 108(3):263-8. PubMed ID: 9036922
    [Abstract] [Full Text] [Related]

  • 15. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.
    Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR.
    Mol Biol Cell; 1992 Feb 01; 3(2):211-20. PubMed ID: 1550962
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
    Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF.
    J Invest Dermatol; 1995 Jul 01; 105(1):44-50. PubMed ID: 7615975
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.